Abstract
American College of Chest Physicians (ACCP) guidelines for venous thromboembolism prophylaxis (VTEP) after total knee arthroplasty (TKA) favor LMWH, pentasaccharides (Fondaparinux), and warfarin over aspirin. However, recent data suggest that ACCP recommended therapies may increase bleeding complications after TKA. To determine the risks and benefits of various VTEP strategies, we compared rates of DVT, PE, surgical site bleeding, and mortality in a large national population of patients who received aspirin, warfarin, LMWH, or Fondaparinux for VTEP after TKA.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
